30 studies found for:    E2609
Show Display Options
Rank Status Study
1 Recruiting Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects
Condition: Healthy Subjects
Interventions: Drug: E2609;   Drug: Placebo
2 Completed An Open-label, Single Dose Study to Determine the Metabolism and Elimination of [14C]E2609 in Healthy Male Subjects
Condition: Metabolism and Elimination
Intervention: Drug: E2609
3 Completed Evaluation of the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of E2609 in Healthy Subjects
Condition: Healthy
Interventions: Drug: E2609;   Drug: Placebo
4 Completed Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
Condition: Alzheimer's Disease
Interventions: Drug: E2609;   Drug: Placebo for E2609
5 Completed A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil
Condition: Healthy Subjects
Interventions: Drug: E2609;   Drug: itraconazole;   Drug: rifampin;   Drug: digoxin;   Drug: donepezil
6 Recruiting A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects
Condition: Healthy Subjects
Interventions: Drug: Placebo;   Drug: E2609;   Drug: Moxifloxacin
7 Completed An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption
Condition: Alzheimer's Disease
Intervention: Drug: E2609
8 Completed Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly Cohort
Condition: Alzheimer's Disease
Interventions: Drug: Drug: E2609;   Drug: Placebo
9 Completed
Has Results
Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE); a Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Enoxaparin;   Drug: Placebo: tablet of Rivaroxaban;   Drug: Placebo: syringes of Enoxaparin
10 Completed
Has Results
Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Biological: adalimumab;   Drug: methotrexate;   Biological: placebo
11 Completed Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE); a Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement
Conditions: Prevention;   Venous Thromboembolism
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Enoxaparin
12 Completed
Has Results
Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA
Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept;   Drug: Placebo
13 Completed Rivaroxban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Enoxaparin
14 Recruiting Glutamate, Hyperarousal and Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention:
15 Completed An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor
Condition: Rheumatoid Arthritis
Intervention:
16 Recruiting Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Exenatide Once Weekly;   Drug: Placebo
17 Not yet recruiting Effect of Andosan in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Dietary Supplement: Mushroom extract
18 Completed
Has Results
An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies
Condition: Rheumatoid Arthritis
Interventions: Drug: Tocilizumab;   Drug: Disease-modifying anti-rheumatic drugs;   Drug: Non-steroidal anti-inflammatory drugs;   Drug: Oral corticosteroids
19 Completed
Has Results
Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Conditions: Meningitis;   Meningococcal Infection
Interventions: Biological: MenACWY-CRM197;   Biological: DTaP (Diptheria, Tetanus, Pertussis) Vaccine;   Biological: Hib (Haemophilus influenza b) Vaccine;   Biological: IPV (Inactivated Polio Vaccine) Vaccine;   Biological: Pneumococcal conjugate Vaccine;   Biological: MMR (Measles, Mumps, and Rubella) Vaccine;   Biological: Varicella Vaccine;   Biological: Hepatitis A Virus
20 Completed Open Label, Zonegran (Zonisamide) In Partial Onset Seizures
Condition: Epilepsy
Intervention: Drug: Zonegran

Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results
Indicates status has not been verified in more than two years